April 4 (Reuters) - Allergan (NYSE:AGN) plc AGN.N :
* ALLERGAN IS CURRENTLY REVIEWING APRIL 4 HEALTH CANADA NOTICE OF ITS INTENT TO SUSPEND CO'S LICENCES FOR BIOCELL BREAST IMPLANTS - SPOKESWOMAN
* ALLERGAN INTENDS TO RESPOND WITHIN THE DEADLINE PROVIDED BY HEALTH CANADA - SPOKESWOMAN Further company coverage: AGN.N